ANXA2 and colorectal carcinoma: XAB2 upregulated ANXA2 expression at the transcriptional level by binding to its promoter, thereby promoting proliferation and DDR in CRC, facilitating oxaliplatin-induced DNA damage repair, and enhancing oxaliplatin resistance.